Marengo Therapeutics

Marengo Therapeutics is a clinical-stage biotech company based in Cambridge, MA. The company is pioneering a novel approach to activate the body's immune system to combat cancer by selectively modulating T cell subsets through its first-in-class antibody libraries targeting variable β chain variants of the T cell receptor.